Sexual Dimorphism and the Immune System

Principles of Gender-Specific Medicine

Volumn 2, Issue , 2004, Pages 1071-1081

  Rider, Virginia ^a   Abdou, Nabih I ^b  

^a PITTSBURG STATE UNIVERSITY   (United States)

^b Center for Rheumatic Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846798714     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012440905-7/50374-1     Document Type: Chapter

References (138)

1. Sex affects health. Exploring the Biological Contributions to Human Health. Does Sex Matter? 2001, 117-172. National Academy Press, Washington, DC. T.M. Wizeman, M.L. Pardue (Eds.).
2. Gabriel SE The epidemiology of gender-discrepant illness. Lupus 1999, 8:339-345.
3. Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopath 1997, 84:223-243.
4. Whitacre CC, Reingold SC, O'Looney PA A gender gap in autoimmunity. Science 1999, 283:1277-1278.
5. Dudley DJ, Chen CL, Mitchell MD, et al. Adaptive immune responses during murine pregnancy: pregnancy-induced regulation of lymphokine production by activated T lymphocytes. Am J Obstet Gynecol. 1993, 168:1155-1163.
6. Hill JA, Polgar K, Anderson DJ T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995, 273:1933-1936.
7. Olsen NJ, Kovasc WJ Gonadal steroids and immunity. Endocrin. Rev. 1996, 17:367-384.
8. Medzhitov R, Janeway CA Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296:298-300.
9. Fujita T Evolution of the lectin-complement pathway and its role in innate immunity. Nature Rev 2002, 2:346-353.
10. Moxley G, Posthuma D, Carlson P, et al. Sexual dimorphism in innate immunity. Arthritis Rheum. 2002, 46:250-258.
11. Beeson PB Age and sex associations of 40 autoimmune diseases. Am J Med. 1994, 96:457-462.
12. Miller L, Hunt JS Sex steroids, hormones and macrophage function. Life Sci. 1996, 59:1-14.
13. Lisse IM, Aaby P, Whittle H, et al. T-lymphocyte subsets in West African children: impact of age, sex, and season. J Pediatr. 1997, 130:77-85.
14. Homo-Delarche F, Fitzpatrick F, Christeff N, et al. Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol. 1991, 40:619-637.
15. Cutulo M, Sulli A, Villaggio B, et al. Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 1998, 57:573-577.
16. Sakaguchi S, Sakaguchi N Role of genetic factors in organ-specific autoimmune diseases induced by manipulating the thymus or T cells, and not self-antigens. Rev Immunogenet 2000, 2:147-153.
17. Theofilopoulos AN, Dummer W, Kono DH T cell homeostasis and systemic autoimmunity. J Clin Invest. 2001, 108:335-340.
18. Whitacre CC Sex differences in autoimmune disease. Nature Immunol. 2001, 2:777-780.
19. Davidson A, Diamond B Autoimmune diseases. N Engl J Med. 2001, 345:340-350.
20. Diamond B, Bluestone J, Wofsy D The immune tolerance network and rheumatic disease. Arthritis Rheum. 2001, 44:1730-1735.
21. Theofilopoulos AN, Kono DH The genes of systemic autoimmunity. Proc Assoc Am Phys. 1999, 111:228-240.
22. Moser KL, Neas BR, Salmon JE, et al. Genome scan of human systemic lupus erythematosus. Evidence for linkage on chromosome 1q in African-American pedigress. Proc Natl Acad Sci USA 1998, 95:14869-14874.
23. Arnett FC Genetic studies of human lupus in families. Int Rev Immunol. 2000, 19:297-317.
24. Mongey AB, Hess EV The role of environment in systemic lupus erythematosus and associated disorders. Dubois' Lupus Erythematosus 1997, 31-37. Williams and Wilkins, Baltimore. D.J. Wallace, B.H. Hahn (Eds.).
25. Lahita RG, Bradlow HL Klinefelter's syndrome: Hormone metabolism in hypogonadal males with systemic lupus erythematosus. J Rheumatol. 1987, 14:154-157.
26. Huang Q, Parfitt A, Grennan DM, et al. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity 1997, 26:85-93.
27. Roper RJ, Griffith JS, Lyttle CR, et al. Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses. Endocrinol. 1999, 140:556-561.
28. Griffith JS, Jensen SM, Lunceford JK, et al. Evidence for the genetic control of estradiol-regulated responses. Implications for variation in normal and pathological hormone-dependent phenotypes. Am J Pathol. 1997, 150:2223-2230.
29. Wendell DL, Gorski J Quantitative trait loci for estrogen-dependent pituitary tumor growth in the rat Mamm. Genome 1997, 8:823-829.
30. Tsai MJ, O'Malley BW Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994, 63:451-486.
31. Zhou ZX, Wong CI, Sar M, et al. The androgen receptor: an overview. Recent Prog Horm Res. 1994, 49:249-274.
32. Misrahi M, Loosfelt H, Atger M, et al. Structural and functional studies of mammalian progesterone receptors. Horm Res. 1990, 33:95-98.
33. Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and overy. Proc Natl Acad Sci USA 1996, 93:5925-5930.
34. Lahita RG Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000, 26:951-968.
35. Cutolo M, Wilder RL Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am. 2000, 26:825-839.
36. Lahita RG, Bradlow HL, Kunkel HG, et al. Increased 16 alpha hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981, 53:174-178.
37. Verthelyi D, Petri M, Tlamus M, et al. Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus 2001, 10:352-358.
38. Suenaga R, Rider V, Evans M, et al. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J Rheumatol 1998, 25:1305-1312.
39. Suenaga R, Rider V, Evans MJ, et al. In vitro-activated human lupus T cells express normal estrogen receptor proteins which bind to the estrogen response element. Lupus 2001, 10:116-122.
40. Rider V, Jones SR, Evans M, et al. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol. 2000, 95:124-134.
41. Kassi EN, Vlachoyiannopoulos PG, Moutsopoulos HM, et al. Molecular analysis of estrogen receptor alpha and beta in lupus patients. Eur J Clin Invest. 2001, 31:86-93.
42. Garovich M, Agudelo C, Pisko E Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum. 1980, 23:1396-1398.
43. Cooper GS, Dooley MA, Treadwell EL, et al. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998, 41:1714-1724.
44. Mund AJ, Simson J, Rothefield N Effect of pregnancy on course of systemic lupus erythematosus. JAMA 1963, 183:109-112.
45. Casoli P, Tumiati B, LaSala G Fatal exacerbation of systemic lupus erythematosus after induction of ovulation. J Rheumatol. 1997, 24:1639-1640.
46. Font J, Pallares L, Cervera R, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis. 1991, 50:702-705.
47. Buyon JP Clinical trials in systemic lupus erythematosus. Curr Rheumatol. Rep. 2000, 2:11-12.
48. Sanchez-Guerrero J, Liang MH, Karlson EW, et al. Post-menopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995, 122:430-433.
49. Karpuzoglu-Sahin E, Zhi-Jun Y, Lengi A, et al. Effects of long-term estrogen treatment on IFN-gamma, IL-2 and IL-4 gene expression and protein synthesis in spleen and thymus of normal C57BL/6 mice. Cytokine 2001, 14:208-217.
50. Roubinian JR, Talal N, Greenspan JS, et al. Effect of castration and sex hormone treatment on survival anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med. 1978, 147:1568-1583.
51. Dhaher YY, Chan K, Greenstein BD, et al. Impaired estrogen priming of progesterone receptors in uterus of MRL/Mp-lpr/lpr mice, a model of systemic lupus erythematosus (SLE). Int J Immunopharmacol 2000, 22:537-547.
52. Roa R, Greenstein BD Evidence for pleomorphism of estrogen receptor capacity and affinity in liver and thymus of immature BALC/c and (NZBxNZW) F1 mice, a model of systemic lupus erythematosus. Int J Immunopharmacol 2000, 22:897-903.
53. Tang B, Matsuda T, Akira S, et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol. 1991, 3:273-278.
54. Törnwall J, Carey AB, Fox RI, et al. Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells. J Gend Specif Med 1999, 2:33-40.
55. Wu WM, Lin BF, Su YC, et al. Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice. Scan J Immunol. 2000, 52:393-400.
56. Apelgren LD, Bailey DL, Fouts RL, et al. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell Immunol. 1996, 173:55-63.
57. Chan OT, Madaio MP, Shlomchik MJ B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 1999, 163:3592-3596.
58. Chan OT, Shlomchik MJ Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation. J Immunol. 2000, 164:1658-1662.
59. Thurmond TS, Murante FG, Staples JE, et al. Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 2000, 141:2309-2318.
60. Smithson G, Couse JF, Lubahn DB, et al. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol. 1998, 161:27-34.
61. Grimaldi CM, Michael DJ, Diamond B Cutting Edge: Expansion and activation of A population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001, 167:1886-1890.
62. Staples JE, Gasiewicz TA, Fiore NC, et al. Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 1999, 163:4168-4174.
63. Peeva E, Grimaldi C, Spatz L, et al. Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest. 2000, 106:1373-1379.
64. Pellegrini I, Lebrun J, Ali S, et al. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol. 1992, 6:1023-1031.
65. Gagnerault MC, Touraine P, Savino W, et al. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol. 1993, 150:5673-5681.
66. Folomeev M, Prokaeva T, Nassonova V, et al. Prolactin levels in men with SLE and RA. J Rheumatol 1990, 17:1569-1570.
67. Neidhart M Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. Br J Rheumatol 1996, 23:476-481.
68. Miranda JM, Prieto RE, Paniagua R, et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus 1998, 7:387-391.
69. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, et al. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 1998, 7:414-419.
70. Walker SE, Jacobson JD Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am. 2000, 26:713-736.
71. McMurray R, Keisler D, Kanuckel K, et al. Prolactin influences autoimmune disease activity in the female NZBW mouse. J Immunol 1991, 147:3780-3787.
72. Simmons DM, Voss JW, Ingraham HA, et al. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 1990, 4:695-711.
73. Sites DP, Siiteri PK Steroids as immunosuppressants in pregnancy. Immunol Rev. 1983, 75:117-138.
74. Arnalich F, Benito-Urbina S, Gonzalez-Gancedo P, et al. Inadequate production of progesterone in women with systemic lupus erythematosus. Br J Rheumatol 1992, 31:247-251.
75. Polgar B, Barakonyi A, Xynos I, et al. The role of gamma/delta T cell receptor positive cells in pregnancy. Am J Reprod Immunol 1999, 41:239-244.
76. Szekeres-Bartho J, Barakonyi A, Par G, et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2002, 1:1037-1048.
77. Lyndon JP, DeMayo FJ, Funk CR, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278.
78. Tibbetts TA, DeMayo F, Rich S, et al. Progesterone receptors in the thymus-are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA 1999, 96:12021-12026.
79. Mok CC, Lau CS Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 2000, 9:252-257.
80. Sequeira JF, Keser G, Greenstein B, et al. Systemic lupus erythematosus: sex hormones in male patients. Lupus 1993, 2:315-317.
81. Olsen NJ, Gu X, Kovasc WJ Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest. 2001, 108:1697-1704.
82. Olsen NJ, Kovacs WJ Effects of androgens on T and B lymphocyte development. Immunol Res. 2001, 23:281-288.
83. Medina KL, Kincade PW Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci USA 1994, 91:5382-5386.
84. Frey-Wettstein M, Craddock CG Testosterone-induced depletion of thymus and marrow lymphocytes as related to lymphopoiesis and hematopoiesis. Blood 1970, 35:257-271.
85. Nakamura K, Kitani A, Strober W Cell contact-dependent immuno-suppression by CD4(+) CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001, 194:629-644.
86. Valujskikh A, Van Vuskirk AM, Orosz CG, et al. A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen. Transplantation 2001, 72:685-693.
87. Walker SE, Allen SH, McMurray RW Prolactin and autoimmune disease. Trends Endocrinol Metab 1993, 4:147-151.
88. Walker SE, McMurray RW, Houri JM, et al. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann NY Acad Sci. 1998, 840:762-772.
89. Van Vollenhoven RF Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother 2002, 3:23-31.
90. Robinzon B, Cutolo M Should dehydroeplandrosterone replacement therapy be provided with glucocorticoids?. Rheumatology 1999, 38:488-495.
91. Lahita RG, Bradlow HL, Ginzler E, et al. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987, 30:241-248.
92. Straub RH, Zeuner M, Anoniou E, et al. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin-2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus. J Rheumatol. 1996, 23:856-861.
93. Vassilopoulos D, Dovacs B, Tsokos GC TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 1995, 155:2269-2281.
94. Blasini AM, Alonzo E, Chacon R, et al. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Lupus 1998, 7:515-523.
95. Wu J, Edberg JC, Gibson AW, et al. Single-nucleotide polymorphisms of T cell receptor zeta chain in patients with systemic lupus erythematosus. Arthritis Rheum. 1999, 42:2601-2605.
96. Yi Y, NcNerney M, Datta SK Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J Immunol. 2000, 165:6627-6634.
97. Tsokos GC, Kammer GM Molecular aberrations in human systemic lupus erythematosus. Mol Med Today 2000, 6:418-424.
98. Nambiar MP, Enydey EJ, Warke VG, et al. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA. Arthritis Rheum. 2001, 44:1336-1350.
99. Odendahl M, Jacobi A, Hansen A, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000, 165:5970-5979.
100. Arce E, Jackson DG, Gill MA, et al. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001, 167:2361-2369.
101. Weiss A, Littman DR Signal transduction by lymphocyte antigen receptors. Cell 1994, 76:263-274.
102. Rider V, Foster RT, Evans M, et al. Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin Immunol Immunopath 1998, 89:171-180.
103. Rider V, Jones S, Evans M, et al. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 2001, 28:2644-2649.
104. Grewal IS, Flavell RA CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol 1998, 16:111-132.
105. Rider V, Abdou NI Gender differences in autoimmunity: Molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 2001, 1:1009-1024.
106. Musgrove EA, Sutherland RL Cell cycle control by steroid hormones. Cancer Biol 1994, 5:381-389.
107. Rider V Progesterone and the control of uterine cell proliferation and differentiation. Front Biosci 2002, 7:d1545-d1555.
108. Jenkins JK, Suwannaroj S, Elbourne KB, et al. 17-β-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A. Int Immunopharmacol 2001, 1:1897-1911.
109. McMurray RW, Suwannaroj S, Ndebele K, et al. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution apoptosis and Bcl-2 protein levels. Pathobio 2001, 69:44-58.
110. Evans M, MacLaughlin S, Marvin RD, et al. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-α production in SLE but not in normal cultures. Clin Immunol Immunopath 1997, 82:258-262.
111. Balomenos D, Martin-Caballero J, Garcia MI, et al. The cell cycle inhibitor p21 controls T cell proliferation and sex-linked lupus development. Nature Med 2000, 6:171-176.
112. Santiago-Raber ML, Lawson BR, Dummer W, et al. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol 2001, 167:4067-4074.
113. Eskdale J, Gallagher G A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenet 1995, 42:444-445.
114. Kube D, Rieth H, Eskdale J, et al. Structural characterisation of the distal 5' flanking region of the human interleukin-10 gene. Genes Immun 2001, 2:181-190.
115. Gibson AW, Edberg JC, Wu J, et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001, 166:3915-3922.
116. Kanda N, Tsudhida T, Tamaki K Estrogen enhancement of anti-double stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999, 42:328-337.
117. Llorente L, Richaud-Patin Y, Garcia-Padilla C, et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 2000, 43:1790-1800.
118. Da Silva JA, Peers SH, Perretti M, et al. Sex steroids affect glucocorticoid response to chronic inflammation and to interleukin-1. J Endocrinol 1993, 136:389-397.
119. Rivier C Stimulatory effect of interleukin-1 beta on the hypothalamic-pituitary-adrenal axis of the rat: influence of age, gender and circulating sex steroids. J Endocrinol 1994, 140:365-372.
120. Erb KJ, Ruger B, von Brevern M, et al. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 1997, 185:329-339.
121. Seery JP, Carroll JM, Cattell V, et al. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon γ in the epidermis. J Exp Med 1997, 186:1451-1459.
122. Giron-Gonzalez JA, Moral FJ, Elvira J, et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000, 143:31-36.
123. McMurray RW, Ndebele K, Hardy KJ, et al. 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001, 14:324-333.
124. Silverstein AM, Rose NR There is only one immune system! The view from immunopathology. Immunol 2000, 12:173-178.
125. Goldrath AW, Bevan MJ Selecting and maintaining a diverse T-cell repertoire. Nature 1999, 402:255-262.
126. Gu H, Tarlinton D, Muller W, et al. Most peripheral B cells in mice are ligand selected. J Exp Med 1991, 173:1357-1371.
127. DiRenzo J, Shang Y, Phelan M, et al. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 2000, 20:7541-7549.
128. Shang Y, Myers M, Brown M Formation of the androgen receptor transcription complex. Cell 2002, 9:601-610.
129. Shang Y, Brown M Molecular determinants for the tissue specificity of SERMs. Science 2002, 295:2465-2468.
130. Ren B, Cam H, Takahashi Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 2002, 16:245-256.
131. Weinmann AS, Yan PS, Oberley MJ, et al. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002, 16:235-244.
132. Ing NH, Ott TL Estradiol up-regulates estrogen receptor-alpha messenger ribonucleic acid in sheep endometrium by increasing its stability. Biol Reprod 1999, 60:134-139.
133. Moroni G, Della Casa Alberighi O, Ponticelli C Combination treatment in autoimmune disease: systemic lupus erythematosus. Springer Semin Immunopathol 2001, 23:75-89.
134. Prud'home GJ, Lawson BR, Theofilopoulos AN Immunotherapeutic gene transfer into muscle. Trends Immunol 2001, 22:149-155.
135. Johnson KL, Nelson JL, Furst DE, et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 2001, 44:1848-1854.
136. Tanaka A, Lindor K, Ansari A, et al. Fetal microchimerism in the mother: immunologic implications. Liver Transpl 2000, 6:138-143.
137. Nelson JL Maternal-fetal immunology and autommune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune. Arthritis Rheum 1996, 39:191-194.
138. Nelson JL HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol 2001, 52:77-84.